Treating chronic lamivudine-resistant hepatitis B in HIV co-infected patients
Benhamou, Y.
Gastroenterologie Clinique et Biologique 30(10 Part 2): 3s22-3s25
2006
ISSN/ISBN: 0399-8320 PMID: 17075492 Document Number: 597720
Document emailed within 1 workday
Related Documents
Bai, H.-l.; Luo, H.-t.; Ye, Y.-n.; Long, H.; Zhong, R.-x. 2010: Observation on effect of peg interferon lphaa-2a treating lamivudine resistant chronic hepatitis B Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 24(3): 230-231Ozgenç, F.; Arikan, C.; Sertoz, R.Y.; Nart, D.; Aydogdu, S.; Yagci, R.V. 2004: Effect of long-term lamivudine in chronic hepatitis B virus-infected children Antiviral Therapy 9(5): 729-732
Deal, C.; Ajana, F.; Canva, V.; Mouton, Y.; Yazdanpanah, Y.; Wattré, P.; Bocket, L. 2002: Evaluation of a quantitative HBV-DNA PCR assay in lamivudine treated hepatitis B-infected patients Annales de Biologie Clinique 60(5): 581-588
Chen, J.-L.; Wang, L.; Yan, J.; Zhang, L.; Yu, H.; Fan, X.-L. 2007: Predictive factors of hepatitis B virus DNA negative conversion among patients with chronic hepatitis B during lamivudine therapy Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 21(3): 273-275
Tran, A.; Longo, F.; Saint-Paul, M.C.; Doglio, A.; Benzaken, S.; Rampal, P. 2000: Long-term lamivudine therapy for interferon-alpha- and/or adenine arabinoside monophosphate-resistant chronic hepatitis B infection. Results of a pilot study Gastroenterologie Clinique et Biologique 24(12): 1234-1235
Xu, J.-h.; Yu, Y.-y.; Si, C.-w.; Chen, X.-y.; Han, Z.-h.; Chen, Y.; Li, X.-y. 2009: A clinical study of viral dynamic change in patients with hepatitis B e antigen positive chronic hepatitis B by lamivudine treatment Zhonghua Yi Xue Za Zhi 89(41): 2902-2905
Van Leeuwen, R.; Lange, J.M.; Nijhuis, M.; Schuurman, R.; Reiss, P.; Danner, S.A.; Boucher, C.A. 1997: Results of long-term follow-up of HIV-infected patients treated with lamivudine monotherapy, followed by a combination of lamivudine and zidovudine Antiviral Therapy 2(2): 79-90
Sarin, S.K.; Kumar, M.; Hissar, S.; Sharma, B.C. 2006: Combination of pegylated interferon and lamivudine for patients with chronic hepatitis B who have failed treatment Hepatobiliary and Pancreatic Diseases International: Hbpd Int 5(3): 374-380
Lanzafame, M.; Nicole, S.; Rizzardo, S.; Piacentini, D.; Chiesi, S.; Lattuada, E.; Diani, E.; Carelli, M.; Vento, S.; Gibellini, D. 2018: Immunovirological outcome and HIV-1 DNA decay in a small cohort of HIV-1-infected patients deintensificated from Abacavir/Lamivudine/Dolutegravir to Lamivudine plus Dolutegravir New Microbiologica 41(4): 262-267
Gartland, M. 2001: AVANTi 3: a randomized, double-blind trial to compare the efficacy and safety of lamivudine plus zidovudine versus lamivudine plus zidovudine plus nelfinavir in HIV-1-infected antiretroviral-naive patients Antiviral Therapy 6(2): 127-134
Perronne, C. 2005: Workshop report treating hepatitis C in HIV-infected patients: where are we now? Antiviral Therapy 10(5): 691-694
Schvoerer, E.; Kabissa, I.; Cotto, E.; Jouvencel, A-Christine.; Balabaud, C.; De Ledinghen, V.; Couzigou, P.; Quinton, Aé.; Schvoerer, C.; Lafon, M-Edith.; Fleury, Hé.; Bernard, P-Henri. 2002: Lamivudine therapy of chronic hepatitis B in three groups of patients: non transplanted patients, liver recipients, and kidney recipients Gastroenterologie Clinique et Biologique 26(1): 62-66
Tseng, T-Chung.; Liu, C-Jen.; Wang, C-Chi.; Chen, P-Jer.; Lai, M-Yang.; Chen, D-Shinn.; Kao, J-Horng. 2009: Association of baseline viral factors with response to lamivudine therapy in chronic hepatitis B patients with high serum alanine aminotransferase levels Antiviral Therapy 14(2): 203-210
Ren, G.-L.; Fang, Y.; Ma, H.-H.; Lei, Y.-F.; Wang, D.; Xu, M.-C.; Wang, P.-Z.; Huang, C.-X.; Nie, O.-H.; Sun, Y.-T.; Bai, X.-F. 2007: The short hairpin RNA driven by polymerase Ii suppresses both wild-type and lamivudine-resistant hepatitis B virus strains Antiviral Therapy 12(6): 865-876
Qian, F.; Qin, J.; Li Dongli; Wang Weihong; Dai, L. 2015: Variability of Reverse Transcriptase Gene and S Gene in Lamivudine-treated Chronic Hepatitis B Patients Bing du Xue Bao 31(4): 433-439
Verhelst, D.; Goffin, E. 2000: Lamivudine for the treatment of chronic hepatitis B New England Journal of Medicine 342(8): 592
Akbar, H.O. 2002: Lamivudine in chronic hepatitis B virus Saudi Medical Journal 23(8): 929-933
Zabek, P.; Opoka-Kegler, J.; Baka, M.; Dyda, T.; Stańczak, G.P.; Stańczak, J.J. 2013: Prevalence of hepatitis C virus mutants resistant to protease inhibitors among Polish HCV genotype 1-infected patients Przeglad Epidemiologiczny 67(3): 411
Zoulim, F. 2000: Long-term treatment with lamivudine for chronic hepatitis B Gastroenterologie Clinique et Biologique 24(12): 1153-1154
Ibragimova, M.M.; Abdurakhmanov, D.T.; Krel', P.E.; Lopatkina, T.N.; Ignatova, T.M.; Popova, I.V. 2003: Efficacy of lamivudine in HBeAg-negative chronic hepatitis B Klinicheskaia Meditsina 81(6): 49-52